¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 

#ÀÎõ°ú¹Î¼º¹æ±¤, #ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°, #ÀÎõ¹æ±¤¿°, #°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°ÇÑÀÇ¿ø, #ÀÎõ¹æ±¤¿°, #±¸¿ùµ¿°ú¹Î¼º¹æ±¤ 

 

 

ÀÎõ°ú¹Î¼º¹æ±¤,,ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°,,ÀÎõ¹æ±¤¿°,,°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°ÇÑÀÇ¿ø,,ÀÎõ¹æ±¤¿°,,±¸¿ùµ¿°ú¹Î¼º¹æ±¤

¾È³çÇϼ¼¿ä. ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä

 

 

ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¹æ±¤¿°, °£Áú¼º¹æ±¤, ¼ºÀξߴ¢Áõ, ¹æ±¤¿°Ä¡·á, ¾ß´¢Áõ, ÀÜ´¢°¨, ¿©Àڹ汤¿°Áõ»ó, °£Áú¼º¹æ±¤¿°, ³²ÀÚÀÜ´¢°¨, ºÓÀº¼Òº¯, ¿©¼ºÀÜ´¢°¨, ¼Òº¯Ç÷´¢, ³²Àڹ汤¿°, Áú¿°ÀÜ´¢°¨, ¾î¸°ÀÌ¿ÀÁܼÒÅÂ, ÀÓ½ÅÁß¿ÀÁܼÒÅÂ, ¿ä½Ç±Ý, ¼Ò¾Æ¹æ±¤¿°, Àý¹Ú´¢, °ú¹Î¼º¹æ±¤, ¿©Àڹ财Åë, ºó´¢, Àü¸³¼±, ¹æ±¤¿°¼Òº¯, ¸¸¼º¹æ±¤¿°µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.

 

 

¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, ¼ÒÇÕÇâ¿ø, ¿Â¿­Ä¡·á, ¸¶»çÁö, ±ÙÀ̿Ͼàħ, ¾îÇ÷¾àħ, ¸Å¼±¿ä¹ý, µµÀο¿ä¹ý, ÁßdzÁ¶±â°ËÁø, Çâ±â¿ä¹ý, ´Ü¼ø¿îµ¿Ä¡·á, ½½¸µ, ·Ñ¸µ, ³Ã¿Â¿å, mechanical therapy, paraffin, Àü±âÀÚ±ØÄ¡·á, Çdz»Ä§, ü¿­Áø´Ü±â, ¾Æ·Î¸¶Å׶óÇÇ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù

 

 

¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç ºÎ»ê »çÇϱ¸ ´Ù´ë1µ¿, Àü³² ¿©¼ö½Ã °øÈ­µ¿, ¿ï»ê ºÏ±¸ »êÇϵ¿, Àü³² ±¸·Ê±º ±¤ÀǸé, °æ³² ÀǷɱº Ä¥°î¸é, ÀüºÏ ÀÍ»ê½Ã ÆȺÀµ¿, ÀÎõ °è¾ç±¸ µ¿¾çµ¿, ºÎ»ê ±ÝÁ¤±¸ ȸµ¿µ¿, °æ±â ¾È¼º½Ã ¼­Àε¿, °æ³² ±èÇؽà ¾î¹æµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ »ó³²µ¿, ºÎ»ê ¿µµµ±¸ ¿µ¼±µ¿3°¡, ÃæºÏ ÃæÁֽà ÁÖ´öÀ¾, °æºÏ ¹®°æ½Ã »ê¾ç¸é, Àü³² ¸ñÆ÷½Ã ÃøÈĵ¿, °æ³² °ÅÁ¦½Ã °ÅÁ¦¸é, ¿ï»ê Áß±¸ ¿Á±³µ¿, °­¿ø °­¸ª½Ã ȸ»êµ¿, Àü³² ¸ñÆ÷½Ã Ãູµ¿1°¡, °æ±â ¾È¼º½Ã ±Ý¼®µ¿, ºÎ»ê ºÏ±¸ È­¸íµ¿, Àü³² ³ªÁֽà »ï¿µµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¼ºÈ£µ¿, °­¿ø ö¿ø±º ±Ù³²¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, Àü³² ¿µ±¤±º ´ë¸¶¸é, °æ³² »çõ½Ã À̱ݵ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ »ïõµ¿2°¡, ¿ï»ê ºÏ±¸ ´Þõµ¿, ÀÎõ °­È­±º ¾ç»ç¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù

 

 

ÀÎõ°ú¹Î¼º¹æ±¤Ä¡·á ãÀ¸½Ã´Â ÀÎõ³íÇöµ¿, ¹è°ð½Åµµ½Ã, ûÇе¿, ¿ëÇöµ¿, µ¿ÀÎõ, ¼þÀǵ¿, À²¸ñµ¿, °è¾ç±¸, ¿ëÀ¯µµ, °¡Á¤µ¿, °£¼®µ¿, ³íÇö°íÀܵ¿, ¼Û¸²µ¿, ºÎõ, µ¿±¸, Áßµ¿, °ü±³µ¿, Á־ȿª, °Ë¾Ï, ¿µÁ¾Çϴõµ½Ã, ¼Ò·¡Æ÷±¸, ³²µ¿±¸, °¡Áµ¿, ºñºÀ¸é, µµ¸²µ¿, ÀÎõÁÖ¾È, ³²¾çÀ¾, ¹®Çе¿, ÀÎõ, ¼±Çе¿, ÀÎõ³íÇö, ¹è°ð, ±¸¿ùµ¿, ¼Ûµµ±¹Á¦µµ½Ã, Áß±¸ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.

 

´õ »ìÆ캸±â

 

1. Gammie A, Kaper M, Dorrepaal C, et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol 2016; 69:361.

2. Herzog AR, Diokno AC, Brown MB, et al. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc 1994; 42:264.

3. Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J 2017; 28:687.

4. Brown JS, Nyberg LM, Kusek JW, et al. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003; 188:S77.

5. Milson I, Altman D, Lapitan, et al.. Epidemiology of urinary and faecal incontinence and pelvic organ prolapse. In: Incontinence, 4th ed., Abrams P, Cardozo L, Khoury S, Wein A (Eds), Health Publications Ltd., Plymouth, UK 2009. p.35.

6. Robinson D, Hanna-Mitchell A, Rantell A, et al. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI-RS 2015. Neurourol Urodyn 2017; 36:876.

7. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101:1388.

8. www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf (Accessed on April 06, 2015).

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°ú¹Î¼º¹æ±¤ ÇÑÀÇ¿ø ÁÖ¸»Áø·á""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û û¶óÇѾà´ÙÀ̾îÆ® ÇÑÀÇ¿ø Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û õȣ¿ª ÇÏ´ÃüÇÑÀÇ¿ø 10¿ù ´Üµ¶¾ÞÄÝÀ̺¥Æ®
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
12 Áßµ¿ÇÑÀÇ¿ø ÃßõÇØ¿ä 2 7,013 2012-11-03
11 ºÎõ¿¡ ¶ó¿ÂÇÑÀÇ¿ø ÁÁ¾Æ¿ä 3 6,954 2012-11-03
10 Å°¿ì¹Ì ÇÑÀÇ¿ø ´Ù´Ï°í ÀÖ¾î¿ä 1 4,809 2012-11-01
9 ±¸¿ùµ¿¿¡ µ¿¿øÇÑÀÇ¿ø¿¡¼­ Ä¡·á¹Þ¾Ò¾î¿ä 5 15,350 2012-11-01
8 ½Å³ó¾¾ ÇÑÀÇ¿øÀÌ À¯¸íÇÑ °ÍÀ¸·Î ¾Ë°í ÀÖ½À´Ï´Ù. 3 17,180 2012-11-01
7 ¸í¿ÁÇå ÇÑÀÇ¿ø ÃßõÇص帳´Ï´Ù. 1 4,392 2012-11-01
6 ±Ý»êÇÑÀÇ¿ø, ±ÝÈ£µ¿¿¡ ÀÖ´Â ±Ý»êÇÑÀÇ¿øÀä 13 11,660 2012-10-29
5 ´õÆíÇѼ¼»óÇÑÀÇ¿ø, ¼Õ¹ßÀú¸²À̳ª °üÀýµîÀÇ ÁúȯÀ̽öó¸é µÐ»êµ¿ÀÇ ´õÆí.. 0 6,277 2012-10-29
4 ÇØÀκκÎÇÑÀÇ¿øÀ» ¼Ò°³Çص帱±î ÇÕ´Ï´Ù 1 8,152 2012-10-23
3 º´ÀÎÇÑÀÇ¿ø, Àú ¼Õ¹ß ¾öû Â÷°¡¿ü´Âµ¥ ¾È¾Ï¿ª º´ÀÎÇÑÀÇ¿ø°¡¼­ ³ª¾Ò¾î¿ä 0 4,810 2012-10-23
2 À¯ÀüÀûÀÎ ÇǺΠ¾Ë·¯Áö Ä¡·á 0 6,261 2012-10-23
1 Áö¼ºÇÑÀÇ¿ø, °­µ¿±¸ µÐÃ̵¿ ½ÃÀå¾Æ½Ã³ª¿ä? °Å±â¿¡ Áö¼ºÇÑÀÇ¿øÀ̶ó°í ÀÖ.. 13 38,936 2012-10-23
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷